Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06168929
Status:
COMPLETED
Last Update Posted:
2024-01-23
First Post:
2023-12-05
Brief Title:
Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Study Overview
Official Title:
Bioequivalence Study of 2 Sizes of SHR4640 Tablets in Healthy Subjects Randomized Open Single Dose Two Sequences Two Cycles Self-Crossover Control
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is being conducted to evaluate the pharmacokinetic and safety of two sizes of SHR4640 tablets in healthy adults to explore the bioequivalence between two sizes of SHR4640 tablets
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None